Cyclosporine: the case for expanding bioequivalence criteria to include measures of individual bioequivalence in relevant population subsets.
D000042:Absorption; D000293:Adolescent; D001682:Biological Availability; D002648:Child; D002675:Child, Preschool; D016572:Cyclosporine / Q000008:administration & dosage / Q000493:pharmacokinetics*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000493:pharmacokinetics*; D007223:Infant; D013810:Therapeutic Equivalency